Chronic Relapsing Multiple Sclerosis: A Case of Rapid Recovery by Application of Weak Electromagnetic Fields

References

• Adams R. D., Victor M. Principles of neurology, 3rd Edition. McGraw-Hill Book Company, New York 1985; 699–717
   Google Scholar
• Aita J. F., Bennet D. R., Anderson R. E. Cranial CT appearance of acute multiple sclerosis. Neurology 1978; 28: 251–255
   PubMed Web of Science ®Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Aldrich M. S. Narcolepsy. Neurology 1992; 4: 2, 34–43, (suppl 6)
   Google Scholar
• Angeli A., Gatti G., Sartori M. L., DelPonte D., Garagnola R. Effect of exogenous melatonin on human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. The pined gland and cancer, D. Gupta, A. Attanasio, R. J. Reiter. Brain Research Promotion, London 1988
   Google Scholar
• Anton-Tay F., Chou C., Anton S. C., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Axelrod J. The pined gland: a neurochemical transducer. Chemical signals from nerves regulate synthesis of melatonin and convey information about internal clocks. Science 1974; 184: 1341–1348
   PubMed Web of Science ®Google Scholar
• Bardasano J. L., Meyer A. J., Picazo L. Ultrastructure of the pineal cells of the homing pigeon Columba livia and magnetic fields (first trials). Journal fuer Hirnforschung 1985; 26: 471–475
   PubMedGoogle Scholar
• Barkhof F., Scheltens P., Frequin S. T. F. M., Nauta J. J. P., Tas M. W., Valk J., Hommes O. R. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. American Journal of Radiology 1992; 159: 1041–1047
   Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Bennett-Levy J. Determinants of performance on the Rey-Osterrieth complex figure test: an analysis, and a new technique for single-case assessment. British Journal of Clinical Psychology 1984; 23: 109–119
   PubMed Web of Science ®Google Scholar
• Berg O., Hanley J. Narcolepsy in 2 cases of multiple sclerosis. Acta Neurologica Scandinavica 1963; 39: 252–257
   PubMed Web of Science ®Google Scholar
• Bennett-Levy J. Determinants of performance on the Rey-Osterrieth complex figure test: an analysis, and a new technique for single-case assessment. British Journal of Clinical Psychology 1984; 23: 109–119
   PubMed Web of Science ®Google Scholar
• Berger J., Sheremata W. Persistent neurological deficit precipitated by hot bath test in MS. Journal of the American Medical Association 1983; 249: 1751–1753
   PubMed Web of Science ®Google Scholar
• Birau N., Mayer C., Matsubayashi K., Meier-Ewert K. H. Melatonin serum concentration during the nocturnal sleep of narcoleptics. IRCS Journal of Medical Science 1982; 10: 814
   Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Bodis-Wollner I., Onofrj M. The visual system in Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; 323–327
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Thornton J. Visual evoked potentials and the severity of Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 126–146
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Mylin L., Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Bourdette D. N. Bladder, bowel and sexual dysfunction. Multiple sclerosis: current status of research and treatment, R. M. Herndon, F. J. Seil. Demos publications, New York 1994; 223–231
   Google Scholar
• Broman T. Blood brain barrier damage in multiple sclerosis: supra-vital test observations. Acta Neurologica Scandinavica 1964; 40: 21–24, (Suppl 10)
   PubMed Web of Science ®Google Scholar
• Carnegie P. R. Relationship of methylarginine to the main encephalitogenic determinant and some speculative implications for multiple sclerosis. Multiple sclerosis progress in research, E. J. Field, T. M. Bell, P. R. Carnegie. North Holland Publishing, Amsterdam 1972; 63–69
   Google Scholar
• Claveria L. E., Curzon C, Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cere-brospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Comings D. E. Serotonin and animal behavior. Tourette syndrome and human behavior, D. E. Comings. Hope Press, Duarte, California 1990; 445–456
   Google Scholar
• Cremer-Bartels G., Krause K., Mitoskas G., Brodersen D. Magnetic field of the earth as additional zeitgeber for endogenous rhythms. Naturwissenschaften 1984; 71: 567–574
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cere-brospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. The avian pineal gland as an independent magnetic sensor. Neuroscience Letters 1985; 62: 119–122
   PubMed Web of Science ®Google Scholar
• Devoino L., Idova G., Alperina E., Cheido M. (1987) Distribution of immunocompetent cells underlying psychoneuroimmunomodulation. Brain neuromediator control mechanisms. Neuroimmune interactions: Proceedings of the second international workshop on neuroimmunomodulation. 1987, B. D. Jankovic, B. M. Markovic, N. H. Spector. Annals of the New York Academy of Sciences, 496: 292–300
   Google Scholar
• Dixey R., Rein G. [3H] Noradrenaline release potentiated in a clonal cell line by low intensity pulsed magnetic fields. Nature 1982; 206: 253–256
   Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Ekbom K. Familial multiple sclerosis associated with narcolepsy. Archives of Neurology 1966; 15: 337–344
   PubMedGoogle Scholar
• Ellison G. W., Myers L. W., Tourtellotte W. W., Baumhefner R. W. Status of immunosuppressive treatment of multiple sclerosis. Multiple, sclerosis; current status of research and treatment, R. M. Herndon, F. J. Seil. Demos Publications, New York 1994; 175–187
   Google Scholar
• Fariello R. G., Bubenik G. A. Melatonin-induced changes in the sensory activation of acute epileptic foci. Neuroscience Letters 1976; 3: 151–155
   PubMedGoogle Scholar
• Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994; 343: 271–275
   PubMed Web of Science ®Google Scholar
• Freedman M., Leach L., Kaplan E., Winocur G., Shulman K. I., Delis D. C. Clock drawing: a neuropsychological analysis. Oxford University Press, New York 1994; 44–78
   Google Scholar
• Frey J., Darbonne C. Fluoxetine suppresses human cataplexy, a pilot study. Neurology 1994; 44: 707–709
   PubMed Web of Science ®Google Scholar
• Gartrell N. Increased libido in women receiving trazodone. American Journal of Psychiatry 1986; 143: 781–782
   PubMed Web of Science ®Google Scholar
• Gawel M. J., Das P., Vincent S. Visual and auditory evoked responses in Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 138–146
   Google Scholar
• Georgi W. Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochenschrift 1961; 91: 605–607
   PubMedGoogle Scholar
• Gessa G. L., Tagliamonte A., Tagliamonte P., Brodie B. B. Essential role of testosterone in the sexual stimulation induced by p-chlorophenylalanine in male animals. Nature 1970; 227: 616–617
   PubMedGoogle Scholar
• Ghatak N. R., Hirano A., Lijtmaer H., Zimmerman H. M. Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology 1974; 30: 484–486
   PubMedGoogle Scholar
• Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Archives of Neurology 1983; 40: 533–536
   PubMedGoogle Scholar
• Godbout R., Montplaisir J. The effect of zimelidine, a serotonin reuptake blocker, on cataplexy and daytime sleepiness of narcoleptic patients. Clinical Neuropharmacology 1986; 9: 46–51
   PubMed Web of Science ®Google Scholar
• Holder G. E., Bartlett J. R., Bridges P. K., Kantamanei B. D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jacobs B. L., Fornal C. A. 5-HT and motor control: a hypothesis. Trends in Neurosciences 1993; 16: 346–352
   PubMed Web of Science ®Google Scholar
• Jacobs L., Kinkel P. R., Kinkel W. R. Silent brain lesions in patients with isolated optic neuritis. Archives of Neurology 1986; 43: 452–455
   PubMedGoogle Scholar
• Jaffe R. A., Laszewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–45
   PubMed Web of Science ®Google Scholar
• Kaplan E. The process approach to neuropsychological assessment of psychiatric patients. Journal of Neuropsychiatry 1990; 2: 72–87
   PubMedGoogle Scholar
• Kawakami M., Yamaoka S., Yamaguchi T. Influence of light and hormones upon circadian rhythm of EEG slow-wave and paradoxial sleep. Advanes in climatic physiology, S. Itoh, K. Ogata, H. Yoshimura. Shoin, Tokyo 1972; 349–366
   Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Kolb B., Whishaw I. Q. Fundamentals of human neuropsychology. W. H. Freeman and Company, New York 1990; 455–456; 233–236; 463–501
   Google Scholar
• Koopmans R. A., Li D. K. B., Oger J. J. F., Mayo J., Paty D. W. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Koya G., Suzuki M., Baba M., Iwabuchi T. An autopsy case of concurrence of multiple sclerosis and glioma. Hirosaki Medical Journal 1977; 29: 588–596
   Google Scholar
• Langdon N., Shindler J., Parkes J. D., Bandak S. Fluoxetine in the treatment of cataplexy. Sleep 1986; 9: 371–372
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Li D. K. B., Mayo J., Fache S., Robertson W., Lastrukoff L. F., Oger J., Paty D. W. Lack of correlation between clinical manifestations and lesions of MS as seen by NMR. Neurology 1984; 34: 136, (suppl)
   PubMed Web of Science ®Google Scholar
• Luca N., Hategan D. Determination of serotonin content and ceruloplasmin activity of blood and CSF amino acid level in multiple sclerosis. Reveu Roumania Medica Neurologica Psychiatrica 1986; 24: 153–159
   Google Scholar
• Lynch S. G., Rose J. W., Smoker W., Petajan J. H. MRI in familial multiple sclerosis. Neurology 1990; 40: 900–903
   PubMed Web of Science ®Google Scholar
• MackKay R. P., Hirano A. Forms of benign multiple sclerosis: report of two clinicaly silent cases discovered at autopsy. Archives of Neurology 1967; 17: 588–600
   PubMedGoogle Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science 1987a; 496: 67–77
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987b; 277–279
   Google Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• McDonald W. I., Barnes D. Lesson from magnetic resonance imaging in multiple sclerosis. Trends in Neuroscience 1989; 12: 376–379
   PubMed Web of Science ®Google Scholar
• McDonald W. I. Pathophysiology of conduction in central nerve fibres. Visual evoked potentials in man: new developments, J. Desmedt. Claredon Pres, Oxford 1977; 423–437
   Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Milner B. Some effects of frontal lobectomy in man. The frontal granular cortex and behavior, J. M. Warren, K. Akert. McGraw-Hill, New York 1964; 313–334
   Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Montplaisir J., Godbout R. Serotoninergic reuptake mechanisms in the control of cataplexy. Sleep 1986; 9: 280–284
   PubMed Web of Science ®Google Scholar
• Morariu M., Klutzow W. F. Subclinical multiple sclerosis. Journal of Neurology 1976; 213: 71–76
   PubMed Web of Science ®Google Scholar
• Mouret J., Coindet J., Chouvet G. Effect of pinealectomy on sleep stages and rhythms of the male rat. Brain Research 1974; 81: 97–105
   PubMedGoogle Scholar
• Namerow N. S., Thompson L. B. Plaques, symptoms, and the remitting course of multiple sclerosis. Neurology 1969; 19: 765–774
   PubMedGoogle Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Onofrj M., Bazzano S., Malatesta G., Gambi D. Pathophysiology of delayed evoked potentials in multiple sclerosis. Functional Neurology 1990; 5: 301–319
   PubMedGoogle Scholar
• Ossenkopp K. P., Cain D. P. Inhibitory effects of acute exposure to low-intensity 60-Hz magnetic fields on electrically kindled seizures in rats. Brain Research 1988; 442: 255–260
   PubMed Web of Science ®Google Scholar
• Osterrieth P. A. Le test de copie d'une figure complexe. Archives de Psychologie 1944; 30: 206–356
   Google Scholar
• Passouant P., Halberg F., Genicot L., Popoviciu L., Baldy-Moulinier M. La periodicite des acces narcoleptiques et le rytme ultradien du sommeil rapide. Revieu Neurologique 1969; 121: 155–164
   PubMedGoogle Scholar
• Pavel S., Goldstein R., Petrescu M. Vasotocin, melatonin and narcolepsy: possible involvement of the pineal gland in its pathophysiological mechanism. Peptides 1980; 1: 281–284
   PubMed Web of Science ®Google Scholar
• Peyser J. M., Rao S. M., LaRocca N. G., Kaplan E. Guidelines for neuropsychological research in multiple sclerosis. Archives of Neurology 1990; 47: 94–97
   PubMed Web of Science ®Google Scholar
• Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 414–420
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience 1988; 39: 25–33
   Web of Science ®Google Scholar
• Pirttila T., Antonen J., Syrjala P., Frey H. T-lymphocyte subpopulation levels and immunoglobulin changes in the cerebrospinal fluid of patients with neurologic disorders. Annals of the New York Academy of Sciences 1987; 496: 691–696
   PubMed Web of Science ®Google Scholar
• Poirier G., Montplaisir J., Dumont M. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987; 37: 693–695
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Prineas J. W. The etiology and pathogenesis of multiple sclerosis. Multiple sclerosis and other demyelinating diseases, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1970; 107–160
   Google Scholar
• Rao N. A. Chronic experimental allergic optic neuritis. Investigative Ophthalmology and Visual Sciences 1981; 20: 159–172
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rascol A., Clanet M., Montastruc J. L., Delage W., Guiraud-Chaumeil B. L-5-hydroxytrophan in the cerebelalr syndrome treatment. Biomedicine 1981; 35: 112–113
   PubMedGoogle Scholar
• Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T cells in active multiple sclerosis: analysis with monoclonal antibodies. New England Journal of Medicine 1980; 303: 125–129
   PubMed Web of Science ®Google Scholar
• Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Archives de Psychologie 1941; 28: 286–340
   Google Scholar
• Romijn H. J. The pineal, a tranquillizing organ. Life Sciences 1978; 23: 2257–2274
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Rosen A. D. Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology 1992; 262: C1418–C1422, (cell physiol, 31)
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M. Magnetic fields stimulate peripheral nerve regeneration in hypophysectomized rats. NeuroReport 1992; 3: 1039–1041
   PubMed Web of Science ®Google Scholar
• Russel D. S. Trauma and multiple sclerosis. Lancet 1964; 1: 978
   Google Scholar
• Sandyk R. Coexisting bipolar affective disorder and multiple sclerosis: The role of the pined gland. International Journal of Neuroscience 1991; 59: 267–270
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic field. International Journal of Neuroscience 1992a; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. The pineal gland and multiple sclerosis, (Editorial). International Journal of Neuroscience 1992b; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. The effects of picotesla range magnetic fields on perceptual organization and visual memory in parkinsonism. International Journal of Neuroscience 1993a; 73: 207–219
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993b; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994a; 77: 203–227
   PubMed Web of Science ®Google Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994b; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields. International Journal of Neuroscience, (in press a)
   Web of Science ®Google Scholar
• Sandyk R. Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience, (in press b)
   Google Scholar
• Sandyk R., Awerbuch G. I. The pineal gland in multiple sclerosis. International Journal of Neuroscience 1991; 61: 61–67
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993a; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience 1993b; 71: 173–182
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. International Journal of Neuroscience 1993c; 71: 147–157
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993a; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993b; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link. International Journal of Neuroscience 1994a; 76: 249–257
   PubMedGoogle Scholar
• Sandyk R., Awerbuch G. I. The relationship of pineal calcification to cerebral atrophy on CT scan in multiple sclerosis. International Journal of Neuroscience 1994b; 76: 71–79
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of picotesla range magnetic fields on visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994; 78: 103–109
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994a; 74: 177–189
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994b; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Schmidt R. F. Grundriss der neurophysiologie. Springer-Verlag, Berlin 1972; 83–87
   Google Scholar
• Schrader H., Goltlibsen O. B., Slomedial G. M. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980; 30: 105–108
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth-strengh magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Sergott R. C., Brown M. J., Silberberger D. H. Remyelination follows antibody-induced central nervous system demyelination. Annals of Neurology 1986; 20: 94–98
   PubMed Web of Science ®Google Scholar
• Shapiro W. R. Treatment of cataplexy with clomipramine. Archives of Neurology 1975; 32: 653–656
   PubMedGoogle Scholar
• Sharma H. S., Dey P. K. Influence of long term immobilization stress on regional blood-brain barrier permeability, cerebral blood blow and 5-HT level in conscious normotensive young rats. Journal of Neurological Sciences 1986a; 72: 61–76
   PubMed Web of Science ®Google Scholar
• Sharma H. S., Dey P. K. Probable involvement of 5-hydroxytryptamine in increased permeability of blood brain barrier under heat stress in young rats. Neuropharmacology 1986b; 25: 161–167
   PubMed Web of Science ®Google Scholar
• Sicuteri F. Serotonin and sex in man. Pharmacological Research Communications 1974; 4: 403–411
   Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Sperber D., Drarsfield K., Maret G., Weisenseel M. H. Oriented growth of pollen tubes in strong magnetic field. Naturwissenschaften 1981; 68: 40–43
   Web of Science ®Google Scholar
• Stenager E., Sterager E. N., Jensen K. Sexual aspects of multiple sclerosis. Seminars in Neurology 1992; 12: 120–124
   PubMedGoogle Scholar
• Stoupel E., Keret R., Assa S., Kaufman H., Shimshoni M., Laron Z. Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity. Neuroendocrinology Letters 1983; 5: 365–368
   Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyin-doleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Tienari P. J., Salonen O., Wikstrom J., Valanne L., Pablo J. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. Journal of Neurology Neurosurgery and Psychiatry 1992; 55: 883–886
   PubMed Web of Science ®Google Scholar
• Trouillas P., Gaval P., Robert J. M., Adeleine P., Jouvet M. Regression de l'ataxie cerebelleuse humaine sous administration a long terme de 5-hydroxytryptophan. C. R. Academic Science (Paris) 1981; 292: 111–119
   Google Scholar
• Uitehaag B. M., Polman C. H., Valk J., Koetsier J. C., Lucas C. J. Magnetic resonance imaging studies in multiple sclerosis twins. Journal of Neurology Neurosurgery and Psychiatry 1989; 52: 1417–1419
   PubMedGoogle Scholar
• Van Woert M. H., Chung Hwang E. Treatment of myoclonus. Disorders of movement, A. Barbeau. MTP Press, LancasterEngland 1981; 59–80
   Google Scholar
• Vost A., Wolochow D. A., Howell D. A. Incidence of infarcts of the brain in heart disease. Journal of Pathology & Bacteriology 1964; 88: 463–470
   PubMedGoogle Scholar
• Vuia O. The benign form of multiple sclerosis: anatomo-clinical aspects. Acta Neurologica Scandinavica 1977; 55: 289–293
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Effects of electromagnetic field exposure on neuroen-docrine function. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 29–50
   Google Scholar
• Wurtman R. J., Axelrod J., Kelly D. E. The pineal. Academic Press, New York 1968
   Google Scholar
• Yarom M., Zurgil N., Zisapel N. Calcium permeability changes and neurotransmitter release in cultured brain neurons. Journal of Biological Chemistry 1985; 260: 16294–16302
   PubMedGoogle Scholar
• Young I. R., Hall A. S., Pallis C. A. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063–1066
   PubMed Web of Science ®Google Scholar
• Younger D. S., Pedley T. A., Thorpy M. J. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 1991; 41: 447–448
   PubMed Web of Science ®Google Scholar